Gilead Sciences (GILD) Other Operating Expenses (2009 - 2026)
Gilead Sciences (GILD) reported Other Operating Expenses of $14.51 billion for Q2 2026, up 728.3% from $1.75 billion a year earlier and up 835.7% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Other Operating Expenses (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Gilead Sciences' Other Operating Expenses came in at $20.37 billion, up 127.7% year-over-year; for FY2025, it came in at $7.85 billion, down 48.0% from FY2024.
- Other Operating Expenses has a five-year compound annual growth rate of -5.7% (FY2020 to FY2025).
- By year, Other Operating Expenses came in at $15.09 billion in FY2024 (+95.9%), $7.7 billion in FY2023 (-17.2%), $9.3 billion in FY2022 (+23.4%) and $7.54 billion in FY2021 (-28.5%).
- The Q2 2026 figure ranks as the highest quarterly Other Operating Expenses in data going back to Q1 2009.
- Year over year, Other Operating Expenses gained in four of the last eight quarters, with growth averaging 93.9%.
- The high point for year-over-year Other Operating Expenses in five years was Q2 2026 (growth of 728.3%); the low point was Q1 2025 (a decline of 77.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.55 billion (Q1 2026), $2.56 billion (Q4 2025) and $1.74 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.51 Bn |
| Mar 31, 2026 | 1.55 Bn |
| Dec 31, 2025 | 2.56 Bn |
| Sep 30, 2025 | 1.74 Bn |
| Jun 30, 2025 | 1.75 Bn |
| Mar 31, 2025 | 1.79 Bn |
| Dec 31, 2024 | 1.57 Bn |
| Sep 30, 2024 | 3.83 Bn |
| Jun 30, 2024 | 1.58 Bn |
| Mar 31, 2024 | 8.11 Bn |
| Dec 31, 2023 | 2.49 Bn |
| Sep 30, 2023 | 1.66 Bn |
| Jun 30, 2023 | 1.68 Bn |
| Mar 31, 2023 | 1.88 Bn |
| Dec 31, 2022 | 1.55 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jun 30, 2022 | 1.77 Bn |
| Mar 31, 2022 | 4.13 Bn |
| Dec 31, 2021 | 3.30 Bn |
| Sep 30, 2021 | 1.29 Bn |
API Access
Gilead Sciences Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();